Background Scarce data are available on what variables affect the risk of transmission of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the development of …

Background Convalescent plasma has been proposed as an early treatment to interrupt the
progression of early COVID-19 to severe disease, but there is little definitive evidence. We …

Background Outpatient monoclonal antibodies are no longer effective and antiviral treatments
for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many …

Background Mass testing for early identification and isolation of infectious COVID-19 individuals
is efficacious for reducing disease spread. Antigen-detecting rapid diagnostic tests (Ag-…

Data on convalescent plasma (CP) treatment in COVID-19 outpatients are scarce. We aimed
to assess whether CP administered during the first week of symptoms reduced the disease …

Background Community-acquired pneumonia (CAP) is a frequent complication of chronic
obstructive pulmonary disease (COPD), but previous studies are often contradictory. …

Transmission rates among children and adults in summer-school settings, implementing strict
preventive measures, were low in comparison with community transmission rates. These …

The increased incidence of COVID-19 cases and deaths in Spain in March 2020 led to the
declaration by the Spanish government of a state of emergency imposing strict confinement …

The study by Lui et al., indicated that an inflammatory immune response is associated with
severe RSV infections in elderly [1, 2]. In children under the age of 5 years respiratory …

Background: During the COVID-19 pandemic, lockdown strategies have been widely used
to contain SARS-CoV-2 virus spread. Children and adolescents are especially vulnerable to …